Navigating Rare Disease: Insights on Methylmalonic Acidemia in Infants

Rare inquiry

Hello Dr.
Hou, my sister's child was diagnosed with methylmalonic acidemia during the newborn screening follow-up.
However, the child had been drinking formula for three months before going to the hospital and has never shown any symptoms.
The growth curve is in the top percentile.
The previous doctors suggested that it might be a B12-responsive type, which could explain the child's stable condition.
The child has been receiving B12 injections once a week and is on a controlled diet.
Now that the child is 8 months old, the biopsy report has finally come out, indicating it is a B12-unresponsive type, which is why the child has not been treated.
The child is now 9 months old, measuring 75 cm and weighing 10 kg, growing well and everything is normal without any symptoms.
I recommend my sister consult with you for a second opinion, as I believe the child has been thriving since birth.
Even if treatment is necessary, it should be appropriate for the child, as there are many foods that the child cannot eat, and I am really worried about this lovely child being adversely affected.
I have tried to schedule an appointment with you, but it seems impossible to see you this month as you are very popular.
Do you have any better suggestions? Thank you so much!

Xiao Ya Yi, 30~39 year old female. Ask Date: 2006/05/05

Dr. Hou Jiawei reply Rare Disease

In general, symptoms of vitamin B12 non-responsive methylmalonic acidemia (MMA) are relatively pronounced and severe.
Even with dietary management, there may be residual effects.
Further understanding is needed to determine whether it is a mild or transient form of MMA.
Additional appointments can be made at W5am Linkou Chang Gung Memorial Hospital or W6pm Taipei Chang Gung Memorial Hospital outpatient clinics.

Reply Date: 2006/05/05

More Info

Methylmalonic Acidemia (MMA) is a rare metabolic disorder that affects the body's ability to process certain proteins and fats. It is caused by a deficiency in the enzyme methylmalonyl-CoA mutase, which is crucial for the metabolism of methylmalonic acid. This condition can lead to a buildup of methylmalonic acid in the body, resulting in various health complications.
In infants, MMA can present with a range of symptoms, including developmental delays, vomiting, lethargy, and metabolic crises. However, as you mentioned, some infants may not show any symptoms for an extended period, especially if they are receiving treatment, such as vitamin B12 supplementation. The fact that your sister's child has been thriving and has not experienced any metabolic crises is a positive sign, but it is essential to continue monitoring and managing the condition carefully.

The distinction between the "B12-responsive" and "B12-nonresponsive" types of MMA is crucial. The B12-responsive type can often be managed effectively with vitamin B12 supplementation, while the B12-nonresponsive type requires more stringent dietary management and possibly other interventions. Since your sister's child has been diagnosed with the B12-nonresponsive type, it is vital to adhere to dietary restrictions to prevent the accumulation of toxic metabolites.

Here are some recommendations for managing MMA in infants:
1. Dietary Management: A specialized diet is critical for infants with MMA. This typically involves limiting protein intake and avoiding foods high in certain amino acids that can exacerbate the condition. Consulting with a metabolic dietitian can help create a tailored meal plan that meets the child's nutritional needs while minimizing the risk of metabolic crises.

2. Regular Monitoring: Regular follow-ups with a metabolic specialist are essential. This includes routine blood tests to monitor levels of methylmalonic acid and other relevant metabolites. Keeping track of growth parameters is also important to ensure the child is developing appropriately.

3. Emergency Plan: Parents should be educated on recognizing signs of metabolic crises, which can include vomiting, lethargy, and changes in behavior. Having an emergency plan in place, including access to emergency medical care, is crucial.

4. Support and Resources: Connecting with support groups for families dealing with MMA can provide emotional support and practical advice. Organizations focused on rare metabolic disorders often have resources and information that can be invaluable.

5. Second Opinions: As you suggested, seeking a second opinion from a specialist in metabolic disorders can provide additional insights and treatment options. It is essential to work with healthcare providers who are experienced in managing rare metabolic conditions.

6. Nutritional Supplements: In some cases, additional supplements such as carnitine may be recommended to help with the metabolism of fatty acids and reduce the burden of toxic metabolites.

7. Education and Advocacy: Educating yourself and your family about MMA and advocating for the child's needs in healthcare settings can empower you to make informed decisions regarding treatment and management.

In conclusion, while it is reassuring that your sister's child is currently healthy and thriving, ongoing management and monitoring are essential for ensuring long-term health. Collaborating with a team of healthcare providers who specialize in metabolic disorders will help navigate the complexities of MMA and provide the best care for the child.

Similar Q&A

Understanding the Differences Between Three Rare Metabolic Disorders

1. Methylmalonic acidemia 2. Isovalerylic acidemia 3. Glutaric acidemia

Dr. Xu Jiaqi reply Rare Disease
1. Methylmalonic Acidemia (MMA): Under normal circumstances, propionic acid is rapidly metabolized into methylmalonic acid, which is then converted into succinic acid by the enzyme methylmalonyl CoA mutase (MMM). Succinic acid is further metabolized by other enzymes into carbon d...

Understanding Methylmalonic Acidemia: Causes, Symptoms, and Genetic Factors

Doctor: Hello, I would like to ask about this condition. My good friend, she and her husband had their second child, who was diagnosed with this rare disease just one month after birth. The doctor mentioned that this rare disease is genetic, but neither of their families has a hi...

Dr. Jian Yingxiu reply Rare Disease
This is an autosomal recessive genetic disorder, where both parents are carriers and do not exhibit symptoms. Each child has a 1 in 4 chance of being affected. If a previous child has been born with this type of disorder, special prenatal testing can be considered to check for th...

Understanding Rare Metabolic Disorders in Infants: A Guide for Parents

Hello, Dr. Jian. My baby has undergone tandem mass spectrometry analysis for metabolic disorders after birth, and the results indicate a suspected positive for argininemia, hyperammonemia/hyperornithinemia/homocitrullinuria (HHH). This is already the result of a retest. Does my b...

Dr. Jian Yingxiu reply Rare Disease
The newborn screening method your baby underwent utilizes "Tandem Mass Spectrometry" to analyze the concentrations of various amino acids, organic acids, and fatty acid metabolites in dried blood spot samples. If the concentration of any detected substance exceeds the s...

Understanding Propionic Acidemia: Follow-Up Testing and Positive Rates

The rate of positive results in confirmatory testing for suspected propionic acidemia in newborn screening is approximately 50%. Propionic acidemia is a rare inherited metabolic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase, which is essential for the me...

Dr. Jian Yingxiu reply Rare Disease
For information on propionic acidemia, please refer to http://ntuh.mc.ntu.edu.tw/gene/genehelp/database/disease/Propionic_acidemia_940429.htm. A positive result in newborn screening does not necessarily indicate that the infant is affected by the disease. Please ensure to follow ...